ACCESS TO INSIGHT
|CORE FACULTY &
|CLINICAL RESEARCH GRANT||RECIPIENTS||CONTACT US|
The Clinical Research Grant supports innovative haemostatic research on patient outcomes, quality of life, and social impacts.
The maximum grant for up to one year is € 70,000.
Areas of interest include, but are not limited to:
In order to maintain a focus on the treatment of haemophilia and other rare bleeding disorders, Access to Insight clinical research grants will not support research focused on:
Applicants should be health care professionals providing care for haemophilia and rare bleeding disorders patients, including nurses, physiotherapists, and psychologists.
It is assumed that a maximum of 20% of the total grant can be assigned to the candidate’s institute as overhead costs.
The quality of the project idea is the main criterion for the proposal evaluation.
The conditions of the Access to Insight programme require that any additional funding for the same project from other sources (e.g. WFH, ISTH-SSC) be declared to both funding sources. We appreciate grant recipients’ cooperation in this regard.